Dynavax (DVAX) Receives $27M Vaccine Purchase Order from CDC

(NEW YORK)–Dynavax Technologies Corp (NASDAQ: DVAX) receives $27.4 million contract purchase order from CDC for adult vaccines. DVAX receives a purchase contract from the Centers of Disease Control (CDC) for $27.4 million for adult vaccines. Some of the vaccines purchased by the CDC were: Hepatitis A adult vaccine Pneumococcal Polysaccharide vaccine Pneumococcal Conjugate (PCV13) vaccine […]

Share
Continue Reading

Great Elm Capital (GEC) Provides Ventilators and Respiratory Care Equipment

(NEW YORK)–Great Elm Capital Group, Inc. (NASDAQ: GEC) offers real possible upside as demand for ventilators and respritory equipment are expected to grow during coronavirus outbreak. Great Elm Capital distributes respiratory care equipment, including positive air pressure equipment and supplies, ventilators and oxygen equipment. On June 12, 2019, the Company acquired the respiratory assets of […]

Share
Continue Reading

FujiFilm (FUJIY) to Ramp Up Production of Avigan for Treatment of COVID19

(NEW YORK–FUJIFILM Corporation (FUJIY) announced it has expanded its manufacturing capacity to increase production of its influenza antiviral drug “Avigan® Tablet” (favipiravir) for treating patients with COVID-19. To further boost the supply of Avigan, Fujifilm is allocating additional capacity at its FUJIFILM Wako Pure Chemical Co., Ltd. facility in Japan, for production of pharmaceutical intermediates […]

Share
Continue Reading